The nine-valent HPV vaccine was conditionally approved for marketing, sparking a national discussion. To my surprise, what everyone is most concerned about is not the protective ability of the vaccine, but the issue of age coverage. Applicable groups of vaccines
Each drug has certain indications and applicable groups. The cervical cancer HPV vaccine is the same as a biological drug. Currently, there are only two varieties on the market. One is GlaxoSmithKline's approved imported bivalent cervical cancer vaccine product, Cervarix, which is suitable for people aged 9-25. Another Merck company, the quadrivalent recombinant human papillomavirus vaccine (Jadaxu), has been approved for import. The approved applicable group in China is 20 to 45 years old, and the applicable group approved in Hong Kong, the United States, Australia and other places is 9 ~45 years old. The 9-price Jiadaxiu is currently approved for women aged 16 to 25. Populations that can be covered
Three types of vaccines can basically cover high-risk groups. The bivalent and quadrivalent vaccines can prevent 70% of cervical cancer, and the nine-valent vaccine can prevent 90% of cervical cancer. The remaining types are mainly used to prevent genital warts. Cervical cancer cases in China account for more than 28% of the world's cases. There are 100,000 new cervical cancer cases and 30,000 deaths every year. China is the third most common cancer among women aged 15 to 44 years old.
In domestic clinical practice, people under the age of 20 will not be injected with Merck’s quadrivalent vaccine. People aged 9 to 19 can only temporarily choose GlaxoSmithKline’s bivalent vaccine because the vaccine used by Merck globally They are all vaccine products of the same quality produced by the same company. This group of people who want to inject the quadrivalent HPV vaccine can currently only choose to inject the quadrivalent vaccine overseas. Vaccination time
It is recommended to vaccinate as early as possible. The World Health Organization believes that people who can be protected by the HPV vaccine are between the ages of 9 and 26, and the most suitable age for vaccination is 11-12 years old. Timing of sexual life
Some women who have sexual intercourse may have been infected because their partner carries a certain HPV virus. Therefore, if the vaccine is injected again like this, the effect may be compromised. It is recommended to do a screening before vaccination. A vaccine more suitable for the Chinese population
Human papillomavirus is divided into different types. According to China’s epidemiological data, the nine-price vaccine may be more suitable for the Chinese population. Conscience says, regarding the HPV vaccine, it is equally important regardless of whether you are married or unmarried, whether you are a man or a woman! Introduction to Dr. Bu Yao
Ph.D., deputy chief pharmacist, senior nutritionist, has 10 years of experience in medication guidance, nutritional consultation and health management. No medicine, no medicine, advocate healthy life, don’t get sick, don’t take medicine!